Migraine resident survival guide: Difference between revisions
MoisesRomo (talk | contribs) No edit summary |
MoisesRomo (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
<br /> | <br /> | ||
==Overview== | ==Overview== | ||
[[Migraine]] is a [[neurology|neurological]] disease best known for severe [[headaches]].. Usually, [[migraine]] causes episodes of severe or moderate [[headache]] (which is often one-sided and pulsating) lasting between several hours to three days, accompanied by [[gastrointestinal]] upsets, such as [[nausea]] and [[vomiting]], and a heightened sensitivity to bright lights ([[photophobia]]) and noise ([[phonophobia]]). Approximately one-third of people who experience [[migraine]] get a preceding [[Aura (symptom)|aura]]. Migraines' secondary characteristics are inconsistent. ''[[#Triggers|Triggers]]'' precipitating a particular episode of [[migraine]] vary widely. The efficacy of the simplest [[treatment]], applying warmth or coolness to the affected area of the [[head]], varies between persons, sometimes worsening the [[migraine]]. | [[Migraine]] is a [[neurology|neurological]] disease best known for severe [[headaches]].<ref>{{cite web | title = NINDS Migraine Information Page | work= National Institute of Neurological Disorders and Stroke, National Institutes of Health | url = http://www.ninds.nih.gov/disorders/migraine/migraine.htm | accessdate=2007-06-25}}</ref><ref>{{cite web | title = Advances in Migraine Prophylaxis: Current State of the Art and Future Prospects| work= National Headache Foundation (CME monograph) | url = http://www.headaches.org/professional/educationresources/PDF/botoxcme.pdf | accessdate=2007-06-25}}</ref><ref>{{cite web | title = Migraine: diagnosis, management, and new treatment options, Gallagher RM, Cutrer FM, University of Medicine and Dentistry of New Jersey, School of Medicine, Stratford, USA| work = The American Journal of Managed Care, PMID: 11859906 | url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=11859906&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus | accessdate=2007-06-25}}</ref> Usually, [[migraine]] causes episodes of severe or moderate [[headache]] (which is often one-sided and pulsating) lasting between several hours to three days, accompanied by [[gastrointestinal]] upsets, such as [[nausea]] and [[vomiting]], and a heightened sensitivity to bright lights ([[photophobia]]) and noise ([[phonophobia]]). Approximately one-third of people who experience [[migraine]] get a preceding [[Aura (symptom)|aura]].<ref>{{cite web |title = Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache, Jan 2007,British Association for the Study of Headache| | url = http://216.25.100.131/upload/NS_BASH/BASH_guidelines_2007.pdf |accessdate=2007-06-25}}</ref> Migraines' secondary characteristics are inconsistent. ''[[#Triggers|Triggers]]'' precipitating a particular episode of [[migraine]] vary widely.<ref name="pmid10204850">{{cite journal |author=Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB |title=The inheritance of migraine with aura estimated by means of structural equation modelling |journal=[[Journal of Medical Genetics]] |volume=36 |issue=3 |pages=225–7 |year=1999 |month=March |pmid=10204850 |pmc=1734315 |doi= |url=http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=10204850 |accessdate=2012-08-30}}</ref><ref name="pmid10496258">{{cite journal |author=Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB |title=The relative role of genetic and environmental factors in migraine without aura |journal=[[Neurology]] |volume=53 |issue=5 |pages=995–9 |year=1999 |month=September |pmid=10496258 |doi= |url=http://www.neurology.org/cgi/pmidlookup?view=long&pmid=10496258 |accessdate=2012-08-30}}</ref> The efficacy of the simplest [[treatment]], applying warmth or coolness to the affected area of the [[head]], varies between persons, sometimes worsening the [[migraine]]. | ||
==Causes== | ==Causes== | ||
Line 27: | Line 27: | ||
==Management== | ==Management== | ||
* Shown below is an [[algorithm]] summarizing the [[treatment]] of [[migraine]] according the American Academy of Neurology guidelines: | * Shown below is an [[algorithm]] summarizing the [[treatment]] of [[migraine]] according the American Academy of Neurology guidelines:<ref name="urlAn Algorithm of Migraine Treatment - touchNEUROLOGY">{{cite web |url=https://touchneurology.com/headache/journal-articles/an-algorithm-of-migraine-treatment/ |title=An Algorithm of Migraine Treatment - touchNEUROLOGY |format= |work= |accessdate=}}</ref><ref name="urlwww.painmedicinenews.com">{{cite web |url=https://www.painmedicinenews.com/Article/PrintArticle?articleID=33453 |title=www.painmedicinenews.com |format= |work= |accessdate=}}</ref><ref name="urlMigraine and Meningitis | JAMA Neurology | JAMA Network">{{cite web |url=https://jamanetwork.com/journals/jamaneurology/article-abstract/579362 |title=Migraine and Meningitis | JAMA Neurology | JAMA Network |format= |work= |accessdate=}}</ref> | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | A01 | | | |A01= Patient presents with a complaint of headache | {{Family tree | | | | A01 | | | |A01= Patient presents with a complaint of [[headache]] | ||
}} | }} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | A01 |-| A02 |-| A03 |-| A04 |-| A05 |-| A06 | |A01= Does patient have new or different headaches in past 6 mo? | {{Family tree | | | | A01 |-| A02 |-| A03 |-| A04 |-| A05 |-| A06 | |A01= Does patient have new or different [[headaches]] in past 6 mo? | ||
| A02= Yes| A03= Evaluate red flags<br> • Systemic symptoms: fever, chills, meningismus<br>• Secondary risk factors: malignancy, immunosuppression <br>• Neurologic symptoms or abnormal signs <br>• Onset: sudden/abrupt <br>• Older age >50 years <br>• Pattern change: first headache or different from previous | | A02= Yes| A03= Evaluate [[red flags]]<br> • Systemic [[symptoms]]: [[fever]], [[chills]], [[meningismus]]<br>• Secondary [[risk factors]]: [[malignancy]], [[immunosuppression]] <br>• [[Neurologic symptoms]] or abnormal signs <br>• Onset: sudden/abrupt <br>• Older age >50 years <br>• Pattern change: first [[headache]] or different from previous | ||
headache history | A04= Yes to any | A05= Appropriate pain management, consultations | headache history | A04= Yes to any | A05= Appropriate pain management, consultations | ||
and admission | A06= Appropriate evaluation for secondary causes}} | and admission | A06= Appropriate evaluation for secondary causes}} | ||
Line 39: | Line 39: | ||
{{Family tree | | | | B01 | | | |B01= No}} | {{Family tree | | | | B01 | | | |B01= No}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= 1. Are headaches recurrent that interfere with work, family or social function?<br> 2. Do headaches last at least 4 h if untreated? | {{Family tree | | | | B01 | | | |B01= 1. Are headaches [[recurrent]] that interfere with work, family or social function?<br> 2. Do headaches last at least 4 h if untreated? | ||
}} | }} | ||
Line 46: | Line 46: | ||
}} | }} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= Diagnose migraine}} | {{Family tree | | | | B01 | | | |B01= Diagnose [[migraine]]}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= Evaluate yellow flags<br>• Drug seeking with underlying chronic pain | {{Family tree | | | | B01 | | | |B01= Evaluate yellow flags<br>• [[Drug]] seeking with underlying [[chronic pain]] | ||
<br>• Recurrent ED visits without appropriate outpatient management/ PCP follow-up or <br>• OARRS report shows opiate use ± multisourcing}} | <br>• Recurrent ED visits without appropriate outpatient management/ PCP follow-up or <br>• OARRS report shows [[opiate]] use ± multisourcing}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= Assess for treatment contraindications: pregnancy, allergies, | {{Family tree | | | | B01 | | | |B01= Assess for treatment contraindications: [[pregnancy]], [[allergies]], | ||
comorbid conditions | comorbid conditions | ||
}} | }} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | A01 | | | |A01= Avoid opioids}} | {{Family tree | | | | A01 | | | |A01= Avoid [[opioids]]}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= Treat with<br> | {{Family tree | | | | B01 | | | |B01= Treat with<br> | ||
Ketorolac 30 mg IVP or 30-60 mg IM<br> +<br> Metoclopramide 10 mg IVP over 2 min or Ondansetron 8 mg IVP<br> +<br>Diphenhydramine 25-50 mg<br> +<br> IVP IV fl uids for hydration | Ketorolac 30 mg IVP or 30-60 mg IM<br> +<br> [[Metoclopramide]] 10 mg IVP over 2 min or [[Ondansetron]] 8 mg IVP<br> +<br>[[Diphenhydramine]] 25-50 mg<br> +<br> IVP IV fl uids for [[hydration]] | ||
}} | }} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | A01 |-| A02 |-| A03 | | | |A01= More than 50% relief? | A02= Yes| A03= Discharge patient<br> 1. Disposition | {{Family tree | | | | A01 |-| A02 |-| A03 | | | |A01= More than 50% relief? | A02= Yes| A03= Discharge patient<br> 1. Disposition | ||
<br> 2. No opiate scripts <br> 3. If responsive to ketorolac, discharge with toradol script 10 mg PO tid for up to 5 days | <br> 2. No opiate scripts <br> 3. If responsive to [[ketorolac]], discharge with toradol script 10 mg PO tid for up to 5 days | ||
<br> 4. If response to sumatriptan, discharge with script <br> 5. If response to DHE, discharge with Migranal nasal spray script or DHE sc script <br> 6. If responsive to valproate, valproic taper 250 tid for 3 d, 250 bid for3 d, 250 qd for 3 d, then stop <br> 7. Discharge with PCP follow-up | <br> 4. If response to [[sumatriptan]], discharge with script <br> 5. If response to [[DHE]], discharge with Migranal nasal spray script or DHE sc script <br> 6. If responsive to [[valproate]], [[valproic]] taper 250 tid for 3 d, 250 bid for3 d, 250 qd for 3 d, then stop <br> 7. Discharge with [[PCP]] follow-up | ||
<br> 8. If no PCP, refer to PCP }} | <br> 8. If no PCP, refer to PCP }} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= No}} | {{Family tree | | | | B01 | | | |B01= No}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= Treat with<br> Sumatriptan: 6 mg sc — may repeat in 1 h if no response. (Max dose 12 mg in 24-h period <br> OR<br> DHE-45: Start with 0.25 mg IVP over 1 min or sc. If needed repeat in 1 h 1 mg IVP over 1 min | {{Family tree | | | | B01 | | | |B01= Treat with<br> [[Sumatriptan]]: 6 mg sc — may repeat in 1 h if no response. (Max dose 12 mg in 24-h period <br> OR<br> [[DHE]]-45: Start with 0.25 mg IVP over 1 min or sc. If needed repeat in 1 h 1 mg IVP over 1 min | ||
or 1 mg sc. or choose an antiemetic: Prochlorperazine 10 mg IVP over 30 sec q2-4h prn | or 1 mg sc. or choose an [[antiemetic]]: [[Prochlorperazine]] 10 mg IVP over 30 sec q2-4h prn | ||
<br> OR<br> Metoclopramide: 10 mg IVP over 2 min | <br> OR<br> [[Metoclopramide]]: 10 mg IVP over 2 min | ||
<br> OR<br> Ondansetron: 4-8 mg IVP over 30 sec }} | <br> OR<br> [[Ondansetron]]: 4-8 mg IVP over 30 sec }} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= More than 50% relief? | {{Family tree | | | | B01 | | | |B01= More than 50% relief? | ||
Line 84: | Line 84: | ||
==Do's== | ==Do's== | ||
* Be aware of patients who describe a sudden severe [[thunderclap headache]], described as the worst [[headache]] of their lives. Perform a non-contrasted [[CT scan]] of the [[head]] to rule out [[subarachnoid hemorrhage]]; if negative, perform a [[lumbar puncture]]. | * Be aware of patients who describe a sudden severe [[thunderclap headache]], described as the worst [[headache]] of their lives. Perform a non-contrasted [[CT scan]] of the [[head]] to rule out [[subarachnoid hemorrhage]]; if negative, perform a [[lumbar puncture]].<ref name="pmid30083630">{{cite journal |vauthors=Montemayor ET, Long B, Pfaff JA, Moore GP |title=Patient with a Subarachnoid Headache |journal=Clin Pract Cases Emerg Med |volume=2 |issue=3 |pages=193–196 |date=August 2018 |pmid=30083630 |pmc=6075496 |doi=10.5811/cpcem.2018.5.38417 |url=}}</ref> | ||
* Distinguish [[migraine]] from [[meningitis]] if in addition of [[Photophobia|photophobi]]<nowiki/>a and [[phonophobia]], [[Neck stiffness|neck stiffnes]]<nowiki/>s and fever coexist. | * Distinguish [[migraine]] from [[meningitis]] if in addition of [[Photophobia|photophobi]]<nowiki/>a and [[phonophobia]], [[Neck stiffness|neck stiffnes]]<nowiki/>s and fever coexist.<ref name="urlMigraine and Meningitis | JAMA Neurology | JAMA Network">{{cite web |url=https://jamanetwork.com/journals/jamaneurology/article-abstract/579362 |title=Migraine and Meningitis | JAMA Neurology | JAMA Network |format= |work= |accessdate=}}</ref> | ||
* Perform an [[MRI]] or [[CT scan]] of the [[head]], if [[intracranial hypertension]] is suspected. Morning predominant headache accompanied by [[vomiting]] supports the [[diagnosis]] of [[Brain tumor|intracranial tumors]]. | * Perform an [[MRI]] or [[CT scan]] of the [[head]], if [[intracranial hypertension]] is suspected. Morning predominant headache accompanied by [[vomiting]] supports the [[diagnosis]] of [[Brain tumor|intracranial tumors]].<ref name="pmid29071043">{{cite journal |vauthors=Sina F, Razmeh S, Habibzadeh N, Zavari A, Nabovvati M |title=Migraine headache in patients with idiopathic intracranial hypertension |journal=Neurol Int |volume=9 |issue=3 |pages=7280 |date=August 2017 |pmid=29071043 |pmc=5641834 |doi=10.4081/or.2017.7280 |url=}}</ref> | ||
==Don'ts== | ==Don'ts== | ||
* Do not administer [[Drospirenone and Ethinyl estradiol]] or [[Norelgestromin and Ethinyl Estradiol]] in patients older than 35. | * Do not administer [[Drospirenone and Ethinyl estradiol]] or [[Norelgestromin and Ethinyl Estradiol]] in patients older than 35.<ref name="urlEthinyl estradiol and norelgestromin (transdermal) Uses, Side Effects & Warnings - Drugs.com">{{cite web |url=https://www.drugs.com/mtm/ethinyl-estradiol-and-norelgestromin-transdermal.html |title=Ethinyl estradiol and norelgestromin (transdermal) Uses, Side Effects & Warnings - Drugs.com |format= |work= |accessdate=}}</ref> | ||
* Do not administer [[Non-steroidal anti-inflammatory drug|NSAIDs]] more than 15 days straight do to possible [[rebound headache]]. | * Do not administer [[Non-steroidal anti-inflammatory drug|NSAIDs]] more than 15 days straight do to possible [[rebound headache]].<ref name="pmid29262094">{{cite journal |vauthors=Aleksenko D, Maini K, Sánchez-Manso JC |title= |journal= |volume= |issue= |pages= |date= |pmid=29262094 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} {{WS}} {{WH}} | {{Reflist|2}} {{WS}} {{WH}} | ||
<references /> | <references /> |
Revision as of 15:57, 18 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo, M.D.
Overview
Migraine is a neurological disease best known for severe headaches.[1][2][3] Usually, migraine causes episodes of severe or moderate headache (which is often one-sided and pulsating) lasting between several hours to three days, accompanied by gastrointestinal upsets, such as nausea and vomiting, and a heightened sensitivity to bright lights (photophobia) and noise (phonophobia). Approximately one-third of people who experience migraine get a preceding aura.[4] Migraines' secondary characteristics are inconsistent. Triggers precipitating a particular episode of migraine vary widely.[5][6] The efficacy of the simplest treatment, applying warmth or coolness to the affected area of the head, varies between persons, sometimes worsening the migraine.
Causes
- Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
- There are no life-threatening causes of migraine, although, migraine should be distinguished from intracranial berry aneurysms ruptures and subarachnoid hemorrhages, which represent real emergencies.
Common Causes
- Allergic reactions
- Bright lights, loud noises, and certain odors or perfumes
- Physical or emotional stress
- Changes in sleep patterns
- Smoking or exposure to smoke
- Skipping meals
- Alcohol
- Caffeine
- Menstrual cycle fluctuations, birth control pills
- Exposure to pesticides (sprayed fruits/vegetables)
- Tension headaches
- Foods containing tyramine (red wine, aged cheese, smoked fish, chicken livers, figs, and some beans), monosodium glutamate (MSG), or nitrates (like bacon, hot dogs, and salami)
- Other foods such as chocolate, nuts, peanut butter, avocado, banana, citrus, onions, dairy products, and fermented or pickled foods.
- Drugs like apremilast, conjugated estrogens, Cidofovir
Management
- Shown below is an algorithm summarizing the treatment of migraine according the American Academy of Neurology guidelines:[7][8][9]
Patient presents with a complaint of headache | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Does patient have new or different headaches in past 6 mo? | Yes | Evaluate red flags • Systemic symptoms: fever, chills, meningismus • Secondary risk factors: malignancy, immunosuppression • Neurologic symptoms or abnormal signs • Onset: sudden/abrupt • Older age >50 years • Pattern change: first headache or different from previous headache history | Yes to any | Appropriate pain management, consultations and admission | Appropriate evaluation for secondary causes | ||||||||||||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||||||||||||||
1. Are headaches recurrent that interfere with work, family or social function? 2. Do headaches last at least 4 h if untreated? | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes to both questions | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnose migraine | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluate yellow flags • Drug seeking with underlying chronic pain • Recurrent ED visits without appropriate outpatient management/ PCP follow-up or • OARRS report shows opiate use ± multisourcing | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Assess for treatment contraindications: pregnancy, allergies, comorbid conditions | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Avoid opioids | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Treat with Ketorolac 30 mg IVP or 30-60 mg IM + Metoclopramide 10 mg IVP over 2 min or Ondansetron 8 mg IVP + Diphenhydramine 25-50 mg + IVP IV fl uids for hydration | |||||||||||||||||||||||||||||||||||||||||||||||||||||
More than 50% relief? | Yes | Discharge patient 1. Disposition
8. If no PCP, refer to PCP | |||||||||||||||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Treat with Sumatriptan: 6 mg sc — may repeat in 1 h if no response. (Max dose 12 mg in 24-h period OR DHE-45: Start with 0.25 mg IVP over 1 min or sc. If needed repeat in 1 h 1 mg IVP over 1 min or 1 mg sc. or choose an antiemetic: Prochlorperazine 10 mg IVP over 30 sec q2-4h prn
OR Ondansetron: 4-8 mg IVP over 30 sec | |||||||||||||||||||||||||||||||||||||||||||||||||||||
More than 50% relief? | |||||||||||||||||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Admit the patient and investigate further | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Be aware of patients who describe a sudden severe thunderclap headache, described as the worst headache of their lives. Perform a non-contrasted CT scan of the head to rule out subarachnoid hemorrhage; if negative, perform a lumbar puncture.[10]
- Distinguish migraine from meningitis if in addition of photophobia and phonophobia, neck stiffness and fever coexist.[9]
- Perform an MRI or CT scan of the head, if intracranial hypertension is suspected. Morning predominant headache accompanied by vomiting supports the diagnosis of intracranial tumors.[11]
Don'ts
- Do not administer Drospirenone and Ethinyl estradiol or Norelgestromin and Ethinyl Estradiol in patients older than 35.[12]
- Do not administer NSAIDs more than 15 days straight do to possible rebound headache.[13]
References
- ↑ "NINDS Migraine Information Page". National Institute of Neurological Disorders and Stroke, National Institutes of Health. Retrieved 2007-06-25.
- ↑ "Advances in Migraine Prophylaxis: Current State of the Art and Future Prospects" (PDF). National Headache Foundation (CME monograph). Retrieved 2007-06-25.
- ↑ "Migraine: diagnosis, management, and new treatment options, Gallagher RM, Cutrer FM, University of Medicine and Dentistry of New Jersey, School of Medicine, Stratford, USA". The American Journal of Managed Care, PMID: 11859906. Retrieved 2007-06-25.
- ↑ "Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache, Jan 2007,British Association for the Study of Headache" (PDF). Retrieved 2007-06-25.
- ↑ Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB (1999). "The inheritance of migraine with aura estimated by means of structural equation modelling". Journal of Medical Genetics. 36 (3): 225–7. PMC 1734315. PMID 10204850. Retrieved 2012-08-30. Unknown parameter
|month=
ignored (help) - ↑ Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB (1999). "The relative role of genetic and environmental factors in migraine without aura". Neurology. 53 (5): 995–9. PMID 10496258. Retrieved 2012-08-30. Unknown parameter
|month=
ignored (help) - ↑ "An Algorithm of Migraine Treatment - touchNEUROLOGY".
- ↑ "www.painmedicinenews.com".
- ↑ 9.0 9.1 "Migraine and Meningitis | JAMA Neurology | JAMA Network".
- ↑ Montemayor ET, Long B, Pfaff JA, Moore GP (August 2018). "Patient with a Subarachnoid Headache". Clin Pract Cases Emerg Med. 2 (3): 193–196. doi:10.5811/cpcem.2018.5.38417. PMC 6075496. PMID 30083630.
- ↑ Sina F, Razmeh S, Habibzadeh N, Zavari A, Nabovvati M (August 2017). "Migraine headache in patients with idiopathic intracranial hypertension". Neurol Int. 9 (3): 7280. doi:10.4081/or.2017.7280. PMC 5641834. PMID 29071043.
- ↑ "Ethinyl estradiol and norelgestromin (transdermal) Uses, Side Effects & Warnings - Drugs.com".
- ↑ Aleksenko D, Maini K, Sánchez-Manso JC. PMID 29262094. Missing or empty
|title=
(help)